| Genetics and cardiovascular disease: Design and development of a DNA biobank. | |
| | |
MedLine Citation:
|
PMID: 20098575 Owner: NLM Status: In-Data-Review |
Abstract/OtherAbstract:
|
Coronary artery disease (CAD) is a complex disease with environmental and genetic determinants. Many other cardiovascular (CV) conditions also have a genetic basis. A positive family history of CV disease in first-degree relatives is a strong independent risk factor for CAD as well as several other cardiac disorders. This genetic susceptibility to CV diseases will be understood more clearly when combined with genomics, proteomics and genotyping.The Department of Cardiology at Gold Coast Hospital (Queensland, Australia) with the Faculty of Health, Science and Medicine at Bond University (Queensland, Australia) established the Gold Coast Cardiovascular DNA bank in 2006. The dataset on each individual volunteer includes coronary angiograms, clinical information (including a coronary risk factor profile), biochemical (including cardiac biomarkers) and hematological parameters, and electrocardiograms and echocardiograms. The establishment of the DNA biobank was associated with several key challenges, both technical and logistic.Given the comprehensive nature of the information gathered, the present study has the added potential of identifying genes associated with nonischemic cardiomyopathies, valvular heart disease, congenital heart diseases and other cardiomyopathies. Pooling data from results obtained here with multiple existing DNA biobanks and registries will help in finding answers to the genetic conundrum in CV diseases. The present DNA biobank will serve as a resource well into the future as the technology and science of medical genetics evolve.The most frequent pathology encountered in the biobank is CAD. The significance of the familial occurrence of CAD has been the focus of research for at least 50 years, with a positive family history of CV disease emerging as an independent predictor of risk in the development of CAD. By applying the knowledge learned from studies on CV genetics together with the data from the DNA biobank, scientists may be able to effectively prevent and treat CV diseases in the future. |
| | |
Authors:
|
Satyajit Rohan Jayasinghe; Akshay Mishra; Angela Van Daal; Edmond Kwan |
Related Documents
:
|
22177625 - Short and valid assessment of apraxia in parkinson's disease. 17525715 - The genetics of iga nephropathy. 7714025 - Progress in the immunogenetics of rheumatoid arthritis. 16334625 - Creutzfeldt-jakob disease. 5423905 - Portal hypertension caused by partial nodular transformation of the liver. 887535 - Free perforation of the small bowel in crohn's disease. |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Experimental and clinical cardiology Volume: 14 ISSN: 1918-1515 ISO Abbreviation: Exp Clin Cardiol Publication Date: 2009 |
Date Detail:
|
Created Date: 2010-01-25 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9715903 Medline TA: Exp Clin Cardiol Country: Canada |
Other Details:
|
Languages: eng Pagination: 33-7 Citation Subset: - |
Affiliation:
|
Gold Coast Hospital, Griffith University; |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
| Comments/Corrections | |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Abdominal perfusion pressure and coronary arterial perfusion pressure in patients undergoing coronar...
Next Document: The relationship between serum ferritin levels and electrocardiogram characteristics in acutely ill ...